Pfizer gets FDA approval for hemophilia B gene therapy Beqvez [Seeking Alpha]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Seeking Alpha
The drugmaker said the therapy is aimed at enabling patients to produce factor IX in their own bodies rather than relying on regular intravenous transfusions of the blood-clotting protein. Pfizer said it is also launching a warranty program for the therapy based on durability of patient response. The warranty is intended to provide greater certainty about the treatment to payers and financial protection against efficacy failure. Beqvez is currently being reviewed by EU regulators and was recently approved for use in Canada. Pfizer added that it also has gene therapy candidates in Phase 3 development for the treatment of hemophilia A and Duchenne muscular dystrophy. Recommended For You More Trending News Recommended For You More Trending News About PFE Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- US Generic Injectables Market Projected to Reach $44.6 Billion by 2032 [Yahoo! Finance]Yahoo! Finance
- Unresectable Hepatocellular Carcinoma: Global Market Forecast at $2.64 Billion by 2028, Dominated by Pfizer, Johnson & Johnson, Roche, Merck & Co, and Bayer [Yahoo! Finance]Yahoo! Finance
- Pharmaceutical Fine Chemicals Market worth USD 246.5 Billion to 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. [Yahoo! Finance]Yahoo! Finance
- Is Pfizer Stock Fully Valued At $28? [Forbes]Forbes
- Lokavant Expands Team to Drive Strategic Direction of AI-Based Clinical Trial Feasibility Solution [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 5/1/24 - Form 4
- 5/1/24 - Form 4
- 5/1/24 - Form 8-K
- PFE's page on the SEC website